Pro Medicus signs R&D agreement with UCSF for Visage AI Accelerator

April 15, 2025 02:30 PM AEST | By Team Kalkine Media

Google News:

Pro Medicus signs R&D agreement with UCSF for Visage AI Accelerator — Image source: Shutterstock

Recent News

Dalai Lama’s 90th: A Global Celebration of Compassion, Peace, and Wisd...

FAIR PLAY MENARINI INTERNATIONAL AWARD, A WAVE OF EMOTIONS MARKS THE 2...

RITFIT's 2025 Strategy: Elevating Home Fitness with Personalized, Prof...

Global Times: Xiamen: A paradigm that combines top-level design with a...

Highlights:

Pro Medicus partners with University of California San Francisco to advance AI in medical imaging.

The collaboration aims to enhance the Visage AI Accelerator platform's capabilities.

The partnership emphasizes the integration of clinical research and engineering for improved imaging efficiency.

The healthcare technology sector is undergoing a significant transformation, driven by the rapid advancements in artificial intelligence (AI). Medical imaging, in particular, is benefiting from AI's ability to enhance diagnostic accuracy and optimize patient care. Companies involved in this field are increasingly focused on leveraging AI to push the boundaries of healthcare innovation.

Pro Medicus' Commitment to AI in Medical Imaging

Pro Medicus (ASX:PME), a leader in medical imaging technology, is strengthening its focus on AI research and development through its Visage AI Accelerator platform. This initiative aims to enhance the capabilities of the platform and provide more precise diagnostic tools for healthcare providers. The company has recently entered into an agreement with the University of California San Francisco (UCSF) to explore the potential applications of AI in medical imaging further.

Strategic Partnership with UCSF

The partnership between Pro Medicus' U.S. subsidiary, Visage Imaging, Inc., and UCSF represents a significant collaboration in the healthcare technology space. UCSF's expertise in clinical research is expected to complement Visage's engineering capabilities, fostering the development of AI solutions that can transform the medical imaging landscape. This collaboration is poised to bring forward new tools and technologies that enhance diagnostic processes and improve healthcare outcomes.

Enhancing the Visage AI Accelerator Platform

Malte Westerhoff, the Global CTO of Visage Imaging, highlighted the importance of this milestone, emphasizing that the Visage AI Accelerator platform aligns the company's engineering expertise with the clinical knowledge of UCSF. The collaboration is expected to yield advanced tools for data de-identification, curation, and analysis, creating a more efficient workflow in medical imaging projects. This enhanced synergy between engineering and clinical research is designed to improve both academic research and commercial applications in the healthcare sector.

Building on a Strong Foundation with UCSF

The agreement between Pro Medicus and UCSF builds upon a prior collaboration, focusing on the Visage 7 Viewer product. This ongoing partnership is now expanding into the AI-driven advancements provided by the Visage AI Accelerator platform. The previous successful collaboration provides a solid foundation for the development of more sophisticated medical imaging solutions that benefit both academic and clinical environments.

Global Healthcare Sector Advancements

The integration of AI in healthcare technology is driving global advancements in diagnostic accuracy and patient care. Pro Medicus' efforts, particularly in the field of medical imaging, are reflective of a larger trend toward incorporating AI to streamline healthcare processes. This technological progression is shaping the future of medical imaging and diagnosis, promising improved patient outcomes and greater efficiency in healthcare delivery.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.